KLOW is a research-grade quad blend combining TB-500 (10mg), BPC-157 (10mg), GHK-Cu (50mg), and KPV (10mg) in a single lyophilized vial. Studied for advanced tissue repair and anti-inflammatory research. ≥99% HPLC-verified. For research use only.
TB-500 + BPC-157 + GHK-Cu + KPV combined in one vial
Every lot independently verified by third-party laboratories
Full Certificate of Analysis with HPLC and composition verification
KLOW is a precision-blended quad-peptide formulation combining TB-500 (10mg), BPC-157 (10mg), GHK-Cu (50mg), and KPV (10mg) in a single lyophilized vial, totaling 80mg of active content.
This blend includes KPV, a tripeptide (Lys-Pro-Val) derived from alpha-melanocyte-stimulating hormone (α-MSH), alongside three extensively researched peptides. Each component has published preclinical literature supporting its biological activity profile.
All components manufactured under cGMP-equivalent protocols. Full COA included with every order.
Supplied as a lyophilized powder. Soluble in sterile water and bacteriostatic water. For research and laboratory use only.
KLOW combines TB-500, BPC-157, GHK-Cu, and KPV in a single 80mg vial. It is intended exclusively for in-vitro and laboratory research applications.
All four components verified at ≥99% purity. COA includes composition verification.
Lyophilized: -20°C long-term, stable at 2–8°C for 90 days. Reconstituted: 2–8°C, use within 28 days. Protect from light.
Yes. Every order includes a COA with HPLC data and composition verification for all four components.
Orders before 2PM EST ship same day. Standard delivery is 2–4 business days within the continental US. All orders include tracking.
Still have questions about KLOW or any of our research compounds?
Contact Our Research Team →
